Pulmonary mucosal dendritic cells in T-cell activation: implications for TB therapy

References

• Naik SH, Metcalf D, van Nieuwenhuijze A et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat. Immunol.7(6), 663–671 (2006).
   PubMed Web of Science ®Google Scholar
• Liu K, Waskow C, Liu X et al. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol.8(6), 578–583 (2007).
   Google Scholar
• Sung SS, Fu SM, Rose CE Jr et al. A major lung CD103 (αE)-β7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol.176(4), 2161–2172 (2006).
   PubMed Web of Science ®Google Scholar
• Jakubzick C, Tacke F, Ginhoux F et al. Blood monocyte subsets differentially give rise to CD103+ and CD103- pulmonary dendritic cell populations. J. Immunol.180(5), 3019–3027 (2008).
   PubMed Web of Science ®Google Scholar
• Maus UA, Koay MA, Delbeck T et al. Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice. Am. J. Physiol. Lung Cell Mol. Physiol.282(6), L1245–L1252 (2002).
   PubMed Web of Science ®Google Scholar
• Vermaelen K, Pauwels R. Accurate and simple discrimination of mouse pulmonary dendritic cell and macrophage populations by flow cytometry: methodology and new insights. Cytometry Part A61A(2), 170–177 (2004).
   Web of Science ®Google Scholar
• Kugathasan K, Roediger E, Small C-L et al. CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naive and antigen-primed T cells. BMC Immunol.9(1), 48 (2008).
   PubMed Web of Science ®Google Scholar
• Cleret A, Quesnel-Hellmann A, Vallon-Eberhard A et al. Lung dendritic cells rapidly mediate anthrax spore entry through the pulmonary route. J. Immunol.178(12), 7994–8001 (2007).
   PubMed Web of Science ®Google Scholar
• Jakubzick C, Tacke F, Llodra J, van Rooijen N, Randolph GJ. Modulation of dendritic cell trafficking to and from the airways. J. Immunol.176(6), 3578–3584 (2006).
   PubMed Web of Science ®Google Scholar
• Wolf AJ, Linas B, Trevejo-Nunez GJ et al.Mycobacterium TB infects dendritic cells with high frequency and impairs their function in vivo. J. Immunol.179(4), 2509–2519 (2007).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Juarrero M, Shim TS, Kipnis A, Junqueira-Kipnis AP, Orme IM. Dynamics of macrophage cell populations during murine pulmonary TB. J. Immunol.171(6), 3128–3135 (2003).
   PubMed Web of Science ®Google Scholar
• Kirby AC, Coles MC, Kaye PM. Alveolar macrophages transport pathogens to lung draining lymph nodes. J. Immunol.183(3), 1983–1989 (2009).
   PubMed Web of Science ®Google Scholar
• Sertl K, Takemura T, Tschachler E et al. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J. Exp. Med.163(2), 436–451 (1986).
   PubMed Web of Science ®Google Scholar
• Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG. Studies on the density, distribution, and surface phenotype of intraepithelial class II major histocompatibility complex antigen (Ia)-bearing dendritic cells (DC) in the conducting airways. J. Exp. Med.173(6), 1345–1356 (1991).
   PubMed Web of Science ®Google Scholar
• Jahnsen FL, Strickland DH, Thomas JA et al. Accelerated antigen sampling and transport by airway mucosal dendritic cells following inhalation of a bacterial stimulus. J. Immunol.177(9), 5861–5867 (2006).
   PubMed Web of Science ®Google Scholar
• del Rio M-L, Rodriguez-Barbosa J-I, Kremmer E, Forster R. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol.178(11), 6861–6866 (2007).
   PubMed Web of Science ®Google Scholar
• GeurtsvanKessel CH, Willart MA, van Rijt LS et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J. Exp. Med.205(7), 1621–1634 (2008).
   PubMed Web of Science ®Google Scholar
• Anis MM, Fulton SA, Reba SM et al. Modulation of pulmonary dendritic-cell function during mycobacterial infection. Infect. Immun.76(2), 671–677 (2007).
   Google Scholar
• Raymond M, Rubio M, Fortin G et al. Selective control of SIRP-α-positive airway dendritic cell trafficking through CD47 is critical for the development of T(H)2-mediated allergic inflammation. J. Allergy Clin. Immunol.124(6), 1333–1342 (2009).
   PubMed Web of Science ®Google Scholar
• Sköld M, Behar SM. TB triggers a tissue-dependent program of differentiation and acquisition of effector functions by circulating monocytes. J. Immunol.181(9), 6349–6360 (2008).
   Google Scholar
• Fahlen-Yrlid L, Gustafsson T, Westlund J et al. CD11chigh dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization. J. Immunol.183(8), 5032–5041 (2009).
   PubMed Web of Science ®Google Scholar
• van Rijt LS, Jung S, KleinJan A et al.In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma. J. Exp. Med.201(6), 981–991 (2005).
   PubMed Web of Science ®Google Scholar
• von Garnier C, Filgueira L, Wikstrom M et al. Anatomical location determines the distribution and function of dendritic cells and other APCs in the respiratory tract. J. Immunol.175(3), 1609–1618 (2005).
   PubMed Web of Science ®Google Scholar
• Varol C, Landsman L, Fogg DK et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med.204(1), 171–180 (2007).
   PubMedGoogle Scholar
• Landsman L, Varol C, Jung S. Distinct differentiation potential of blood monocyte subsets in the lung. J. Immunol.178(4), 2000–2007 (2007).
   PubMed Web of Science ®Google Scholar
• Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J. Immunol.179(6), 3488–3494 (2007).
   PubMed Web of Science ®Google Scholar
• de Heer HJ, Hammad H, Soullie T et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med.200(1), 89–98 (2004).
   PubMed Web of Science ®Google Scholar
• Masten BJ, Olson GK, Tarleton CA et al. Characterization of myeloid and plasmacytoid dendritic cells in human lung. J. Immunol.177(11), 7784–7793 (2006).
   PubMed Web of Science ®Google Scholar
• Wang H, Peters N, Schwarze J. Plasmacytoid dendritic cells limit viral replication, pulmonary inflammation, and airway hyperresponsiveness in respiratory syncytial virus infection. J. Immunol.177(9), 6263–6270 (2006).
   PubMed Web of Science ®Google Scholar
• Reljic R, Sano CD, Crawford C et al. Time course of mycobacterial infection of dendritic cells in the lungs of intranasally infected mice. Tuberculosis (Edinburgh, Scotland)85(1), 81–88 (2005).
   Google Scholar
• Ernst JD. Macrophage receptors for Mycobacterium TB. Infect. Immun.66(4), 1277–1281 (1998).
   PubMed Web of Science ®Google Scholar
• Tailleux L, Schwartz O, Herrmann J-L et al. DC-SIGN is the major Mycobacterium TB receptor on human dendritic cells. J. Exp. Med.197(1), 121–127 (2003).
   PubMed Web of Science ®Google Scholar
• Tailleux L, Pham-Thi N, Bergeron-Lafaurie A et al. DC-SIGN induction in alveolar macrophages defines privileged target host cells for mycobacteria in patients with TB. PLoS Med.2(12), e381 (2005).
   Web of Science ®Google Scholar
• Balboa L, Romero MM, Yokobori N et al.Mycobacterium TB impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile. Immunol. Cell Biol.88, 716–726 (2010).
   PubMedGoogle Scholar
• Gupta D, Sharma S, Singhal J et al. Suppression of TLR2-induced IL-12, reactive oxygen species, and inducible nitric oxide synthase expression by Mycobacterium TB antigens expressed inside macrophages during the course of infection. J. Immunol.184(10), 5444–5455 (2010).
   PubMed Web of Science ®Google Scholar
• Bodnar KA, Serbina NV, Flynn JL. Fate of Mycobacterium TB within murine dendritic cells. Infect. Immun.69(2), 800–809 (2001).
   PubMed Web of Science ®Google Scholar
• Ordway D, Henao-Tamayo M, Orme IM, Gonzalez-Juarrero M. Foamy macrophages within lung granulomas of mice infected with Mycobacterium TB express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family. J. Immunol.175(6), 3873–3881 (2005).
   PubMed Web of Science ®Google Scholar
• Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. Foamy macrophages and the progression of the human TB granuloma. Nat. Immunol.10(9), 943–948 (2009).
   PubMed Web of Science ®Google Scholar
• Bafica A, Scanga CA, Feng CG et al. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium TB. J. Exp. Med.202(12), 1715–1724 (2005).
   PubMed Web of Science ®Google Scholar
• Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G. CCL5 participates in early protection against Mycobacterium TB. J. Leukoc. Biol.87(6), 1153–1165 (2010).
   Google Scholar
• Peters W, Cyster JG, Mack M et al. CCR2-dependent trafficking of F4/80dim macrophages and CD11cdim/intermediate dendritic cells is crucial for T cell recruitment to lungs infected with Mycobacterium TB. J. Immunol.172(12), 7647–7653 (2004).
   PubMedGoogle Scholar
• Wolf AJ, Desvignes L, Linas B et al. Initiation of the adaptive immune response to Mycobacterium TB depends on antigen production in the local lymph node, not the lungs. J. Exp. Med.205(1), 105–115 (2008).
   PubMed Web of Science ®Google Scholar
• Tian T, Woodworth J, Sköld M, Behar SM. In vivo depletion of CD11c+ cells delays the CD4+ T cell response to Mycobacterium TB and exacerbates the outcome of infection. J. Immunol.175(5), 3268–3272 (2005).
   PubMed Web of Science ®Google Scholar
• Jung S, Unutmaz D, Wong P et al.In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity17(2), 211–220 (2002).
   PubMed Web of Science ®Google Scholar
• Kashino SS, Vallerskog T, Martens G et al. Initiation of acquired immunity in the lungs of mice lacking lymph nodes after infection with aerosolized Mycobacterium TB. Am. J. Pathol.176(1), 198–204 (2010).
   PubMed Web of Science ®Google Scholar
• Day TA, Koch M, Nouailles G et al. Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during TB. Eur. J. Immunol.40(6), 1663–1673 (2010).
   Google Scholar
• Sallusto F, Schaerli P, Loetscher P et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol.28(9), 2760–2769 (1998).
   PubMed Web of Science ®Google Scholar
• Dieu M-C, Vanbervliet B, Vicari A et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med.188(2), 373–386 (1998).
   PubMed Web of Science ®Google Scholar
• Sanchez-Sanchez N, Riol-Blanco L, Rodriguez-Fernandez JL. The multiple personalities of the chemokine receptor CCR7 in dendritic cells. J. Immunol.176(9), 5153–5159 (2006).
   PubMed Web of Science ®Google Scholar
• Olmos S, Stukes S, Ernst JD. Ectopic activation of Mycobacterium TB-specific CD4+ T cells in lungs of CCR7-/- mice. J. Immunol.184(2), 895–901 (2010).
   Google Scholar
• McCormick S, Santosuosso M, Small CL et al. Mucosally delivered dendritic cells activate T cells independently of IL-12 and endogenous APCs. J. Immunol.181(4), 2356–2367 (2008).
   PubMed Web of Science ®Google Scholar
• Khader SA, Partida-Sanchez S, Bell G et al. Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium TB infection. J. Exp. Med.203(7), 1805–1815 (2006).
   PubMed Web of Science ®Google Scholar
• Gao X, Wang S, Fan Y et al. CD8+DC, but not CD8–DC, isolated from BCG-infected mice reduces pathological reactions induced by mycobacterial challenge infection. PLoS One5(2), e9281 (2010).
   Google Scholar
• Edelson BT, KC W, Juang R et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8α+ conventional dendritic cells. J. Exp. Med.207(4), 823–836 (2010).
   PubMed Web of Science ®Google Scholar
• Reiley WW, Calayag MD, Wittmer ST et al. ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium TB infection are initiated in the mediastinal lymph nodes. Proc. Natl Acad. Sci. USA105(31), 10961–10966 (2008).
   PubMed Web of Science ®Google Scholar
• Shaler CR, Kugathasan K. McCormick S et al. Pulmonary mycobacterial granuloma: increased IL-10 production contributes to establishing a symbiotic host–microbe microenviroment. Am. J. Path. (2010) (In Press).
   Google Scholar
• Divangahi M, Chen M, Gan H et al.Mycobacterium TB evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol.10(8), 899–906 (2009).
   PubMed Web of Science ®Google Scholar
• Divangahi M, Desjardins D, Nunes-Alves C, Remold HG, Behar SM. Eicosanoid pathways regulate adaptive immunity to Mycobacterium TB. Nat. Immunol.11(8), 751–758 (2010).
   PubMed Web of Science ®Google Scholar
• Wakeham J, Wang J, Xing Z. Genetically determined disparate innate and adaptive cell-mediated immune responses to pulmonary Mycobacteriumbovis BCG infection in C57BL/6 and BALB/c mice. Infect. Immun.68(12), 6946–6953 (2000).
   Google Scholar
• Martins de Sousa E, Bonfim de Bortoli F, Amaral EP et al. Acute immune response to Mycobacterium massiliense in C57BL/6 and BALB/c mice. Infect. Immun.78(4), 1571–1581 (2010).
   Google Scholar
• Chackerian AA, Alt JM, Perera TV, Dascher CC, Behar SM. Dissemination of Mycobacterium TB is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun.70(8), 4501–4509 (2002).
   PubMed Web of Science ®Google Scholar
• Cardona P-J, Gordillo S, Diaz J et al. Widespread bronchogenic dissemination makes DBA/2 mice more susceptible than C57BL/6 mice to experimental aerosol infection with Mycobacterium TB. Infect. Immun.71(10), 5845–5854 (2003).
   Google Scholar
• Divangahi M, Yang T, Kugathasan K et al. Critical negative regulation of Type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection. J. Immunol.179(6), 4015–4026 (2007).
   Google Scholar
• Chu CL, Yu YL, Shen KY et al. Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcR&ggr. Eur. J. Immunol.38(1), 166–173 (2008).
   Google Scholar
• Bouchon A, Hernandez-Munain C, Cella M, Colonna M. A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells. J. Exp. Med.194(8), 1111–1122 (2001).
   PubMed Web of Science ®Google Scholar
• Lanier LL. DAP10- and DAP12-associated receptors in innate immunity. Immunol. Rev.227(1), 150–160 (2009).
   PubMedGoogle Scholar
• Ronan EO, Lee LN, Beverley PCL, Tchilian EZ. Immunization of mice with a recombinant adenovirus vaccine inhibits the early growth of Mycobacterium TB after infection. PLoS One4(12), e8235 (2009).
   PubMed Web of Science ®Google Scholar
• Rodrigues LC, Pereira SM, Cunha SS et al. Effect of BCG revaccination on incidence of TB in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet366(9493), 1290–1295 (2005).
   PubMed Web of Science ®Google Scholar
• Group KPT. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and TB in Malawai. Lancet366, 1290–1295 (1996).
   Google Scholar
• Cardona PJ, Amat I, Gordillo S et al. Immunotherapy with fragmented Mycobacterium TB cells increases the effectiveness of chemotherapy against a chronical infection in a murine model of TB. Vaccine23(11), 1393–1398 (2005).
   PubMed Web of Science ®Google Scholar
• Birkholz K, Schwenkert M, Kellner C et al. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Blood116(13), 2277–2285 (2010).
   PubMed Web of Science ®Google Scholar
• Bonifaz LC, Bonnyay DP, Charalambous A et al.In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med.199(6), 815–824 (2004).
   PubMed Web of Science ®Google Scholar
• Bivas-Benita M, van Meijgaarden KE, Franken KL et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium TB. Vaccine22(13–14), 1609–1615 (2004).
   PubMed Web of Science ®Google Scholar
• Rosada RS, de la Torre LG, Frantz FG et al. Protection against TB by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes. BMC Immunol.9, 38 (2008).
   PubMed Web of Science ®Google Scholar
• Roediger EK, Kugathasan K, Zhang X, Lichty BD, Xing Z. Heterologous boosting of recombinant adenoviral prime immunization with a novel vesicular stomatitis virus-vectored TB vaccine. Mol. Ther.16(6), 1161–1169 (2008).
   PubMed Web of Science ®Google Scholar
• Malowany JI, McCormick S, Santosuosso M et al. Development of cell-based TB vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts. Mol. Ther.13(4), 766–775 (2006).
   PubMed Web of Science ®Google Scholar
• Dietz AB, Bulur PA, Brown CA, Pankratz VS, Vuk-Pavlovic S. Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression. Gene Ther.8(5), 419–423 (2001).
   Google Scholar
• Antonelli LRV, Gigliotti Rothfuchs A, Gonçalves R et al. Intranasal poly-IC treatment exacerbates TB in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest.120(5), 1674–1682 (2010).
   PubMed Web of Science ®Google Scholar
• Santosuosso M, Zhang X, McCormick S et al. Mechanisms of mucosal and parenteral TB vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J. Immunol.174(12), 7986–7994 (2005).
   PubMed Web of Science ®Google Scholar
• DeFrancesco L. Landmark approval for Dendreon’s cancer vaccine. Nat. Biotech.28(6), 531–532 (2010).
   PubMedGoogle Scholar
• Kim TW, Hung CF, Boyd D et al. Enhancing DNA vaccine potency by combining a strategy to prolong dendritic cell life with intracellular targeting strategies. J. Immunol.171(6), 2970–2976 (2003).
   PubMed Web of Science ®Google Scholar